# CS DNA MVA Trial in Mampong, Ghana

> **NCT00377494** · PHASE1 · WITHDRAWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Plasmodium Falciparum Malaria

## Interventions

- **BIOLOGICAL:** MVA-CSO Vaccine
- **BIOLOGICAL:** PfCSP DNA (VCL-2510) Vaccine

## Key facts

- **NCT ID:** NCT00377494
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2008-07
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00377494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00377494, "CS DNA MVA Trial in Mampong, Ghana". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00377494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*